Korro Bio (KRRO) Asset Utilization Ratio (2020 - 2026)
Korro Bio's (KRRO) quarterly Asset Utilization Ratio came in at 0.01 in Q2 2026, down 58.19% on a YoY basis from 0.03 in Q2 2025, and down 46.92% quarter-over-quarter from 0.03 in Q1 2026.
Analysis
Korro Bio (KRRO) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Korro Bio (KRRO) has reported Asset Utilization Ratio for 6 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 58.19% year-over-year to 0.01; the trailing twelve-month figure through Jun 2026 stood at 0.01 (down 58.19% YoY), and the FY2025 full-year result was 0.04, up 271.06% from the prior year.
- Asset Utilization Ratio declined to 0.01 in Q2 2026 per KRRO's latest filing, from 0.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.05 in Q1 2022 and bottomed at 0.01 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.03 across 4 years, with a median of 0.03 in 2026.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio sank 60.41% in 2022, then jumped 380.72% in 2025.
- Over 4 years, Asset Utilization Ratio stood at 0.05 in 2022, then tumbled by 82.02% to 0.01 in 2024, then surged by 380.72% to 0.05 in 2025, then slumped by 70.47% to 0.01 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.03, and 0.05 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | 0.00 |
| 10 | Korro Bio | 227.98 Mn | 112.95 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.01 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.15 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.15 |
| Sep 30, 2020 | 0.14 |
| Jun 30, 2020 | 0.21 |